Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -8.46%21.91M | 6.61%20.7M | -13.69%20.68M | 2.61%93.47M | 26.29M | 23.94M | 19.42M | 23.96M | 14.99%91.09M | -0.69%79.22M |
| Cost of revenue | -17.67%14.59M | 8.90%16.25M | -9.34%14.58M | 8.71%66.43M | 17.79M | 17.72M | 14.93M | 16.08M | 9.74%61.11M | 4.97%55.68M |
| Gross profit | 17.80%7.32M | -1.00%4.45M | -22.57%6.1M | -9.84%27.03M | 8.5M | 6.21M | 4.49M | 7.88M | 27.40%29.98M | -11.91%23.54M |
| Operating expense | 17.94%6.73M | -32.93%4.43M | 18.93%4.87M | 37.04%22.6M | 6.24M | 5.71M | 6.61M | 4.09M | 38.87%16.49M | 1.46%11.88M |
| Staff costs | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 8.19%2.31M | 21.55%2.14M |
| Selling and administrative expenses | 18.18%6.6M | -31.32%4.43M | 18.93%4.87M | 34.63%22.06M | --5.98M | --5.58M | --6.45M | --4.09M | 84.14%16.38M | -2.76%8.9M |
| -Selling and marketing expense | 12.78%4.37M | -27.72%2.91M | 18.67%3.32M | 48.79%14.9M | --4.3M | --3.87M | --4.03M | --2.8M | 27.38%10.01M | -3.20%7.86M |
| -General and administrative expense | 30.43%2.23M | -37.30%1.52M | 19.51%1.55M | 12.37%7.16M | --1.68M | --1.71M | --2.42M | --1.3M | 514.41%6.37M | 0.68%1.04M |
| Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2.53%539K | 6.96%553K |
| -Depreciation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2.53%539K | 6.96%553K |
| Rent and land expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -53.04%54K | -22.82%115K |
| Other operating expenses | 7.09%136K | ---- | ---- | 403.88%543.04K | --256K | --127K | --155K | ---- | -73.19%107.77K | 20.00%402K |
| Total other operating income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | 11.65%230K |
| Operating profit | 16.30%585K | 100.71%15K | -67.47%1.23M | -67.14%4.43M | 2.26M | 503K | -2.12M | 3.78M | 15.72%13.49M | -22.34%11.66M |
| Net non-operating interest income (expenses) | -61.88%-259K | 59.96%-213K | 60.42%-205K | -0.61%-1.36M | -144K | -160K | -532K | -518K | -131.02%-1.35M | 1.02%-583K |
| Non-operating interest income | -7.69%12K | 233.33%20K | --13K | 284,647.37%54.1K | --35K | --13K | --6K | --0 | --19 | --0 |
| Non-operating interest expense | 56.65%271K | -56.69%233K | -57.92%218K | 4.63%1.41M | --179K | --173K | --538K | --518K | 159.01%1.35M | -0.95%520K |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -41.27%37K | -1.56%63K |
| Net investment income | 165.37%22.88K | -123.18%-35K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 0 | ||||||||
| Income from associates and other participating interests | 171K | 0 | ||||||||
| Special income (charges) | 15.09%148.92K | 6.06%129.4K | 139.87%122K | |||||||
| Less:Impairment of capital assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 |
| Less:Other special charges | ---- | ---- | ---- | 75.25%-30K | ---- | ---- | ---- | ---- | -98.72%-121.22K | -52.50%-61K |
| Less:Write off | ---- | ---- | ---- | -1,354.49%-118.92K | ---- | ---- | ---- | ---- | 86.60%-8.18K | -136.31%-61K |
| Other non-operating income (expenses) | 41.18%72K | 4,200.00%129K | 700.00%24K | 97.12%37.23K | 124K | 51K | 3K | 3K | -53.93%18.89K | 141.18%41K |
| Income before tax | 44.42%569K | 97.39%-69K | -67.88%1.05M | -73.50%3.26M | 2.24M | 394K | -2.64M | 3.27M | 9.92%12.32M | -19.58%11.2M |
| Income tax | 74.33%-67K | 103.45%147K | -65.52%270K | -194.49%-3.32M | 424K | -261K | -4.27M | 783K | 35.57%3.51M | -20.09%2.59M |
| Net income | -2.90%636K | -113.33%-216K | -68.62%780K | -25.25%6.58M | 1.82M | 655K | 1.62M | 2.49M | 2.21%8.8M | -19.42%8.61M |
| Net income continuous operations | -2.90%636K | -113.33%-216K | -68.62%780K | -25.25%6.58M | --1.82M | --655K | --1.62M | --2.49M | 2.21%8.8M | -19.42%8.61M |
| Noncontrolling interests | -85.00%-37K | 21.74%-18K | 0.00%-17K | -11.57%-79.71K | -20K | -20K | -23K | -17K | -40.09%-71.45K | -610.00%-51K |
| Net income attributable to the company | -0.30%673K | -112.04%-198K | -68.16%797K | -24.95%6.66M | 1.84M | 675K | 1.64M | 2.5M | 2.44%8.88M | -18.87%8.67M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -0.30%673K | -112.04%-198K | -68.16%797K | -24.95%6.66M | 1.84M | 675K | 1.64M | 2.5M | 2.44%8.88M | -18.87%8.67M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 0.00%0.0018 | -109.43%-0.0005 | -76.34%0.0022 | -15.83%0.0202 | 0.005 | 0.0018 | 0.0053 | 0.0093 | 2.44%0.024 | -18.87%0.0234 |
| Diluted earnings per share | 0.00%0.0018 | -109.43%-0.0005 | -76.34%0.0022 | -15.83%0.0202 | 0.005 | 0.0018 | 0.0053 | 0.0093 | 2.44%0.024 | -18.87%0.0234 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.